De la Fuente Lab — Machine Biology Group
We use the power of machines to accelerate discovery in biology and medicine.

Interface with all APEX models
ApexSuite
Models
ApexHemo
Hemolysis prediction
Evaluates hemolytic activity against red blood cells to screen for non-toxic peptide candidates.
ApexTox
Cytolysis prediction
Predicts mammalian cytotoxicity and cytolytic activity to prioritize safe therapeutic sequences.
Applications
AMPSpace
Design for druggability
Makes druggability a design goal, one loop generates, recognizes and ranks peptides for potency, safety, stability and structure at once.
Other Models
Termini
Terminal modifications chemistry by design
Designs antimicrobial and safe peptides together with their terminal chemistry, N-terminal acetylation and C-terminal amidation.
Key Areas of Focus
Antibiotics AI
We develop AI systems that learn the organizing principles of antimicrobial activity, enabling us to search vast biological and chemical spaces and discover new antibiotics beyond the reach of conventional approaches.
Molecular De-Extinction
We use AI to explore the molecular information preserved in extinct life, recovering functional molecules shaped by ancient evolution and testing whether the past can provide new solutions to present-day disease.
Encrypted Immunity
We investigate how ordinary proteins and overlooked genomic sequences encode latent defense molecules, revealing encrypted immunity as a previously unrecognized layer of the immune system.
Peptide Design
We build computational systems that learn how peptide sequence gives rise to structure and function, enabling us to design new molecules with programmable properties for medicine, biotechnology, and beyond.